Cover Image for AI in Synthetic Biology: Engineering Tomorrow’s Molecules, Drugs and Crops

Presented by

In our bi-monthly idalab Seminar series, we invite practitioners, entrepreneurs, investors, and researchers to reflect on their work at the intersection of AI, Life Science, and Healthcare. Talk and Q&A, followed by drinks.

Hosted By

AI

AI in Synthetic Biology: Engineering Tomorrow’s Molecules, Drugs and Crops

Name: AI in Synthetic Biology: Engineering Tomorrow’s Molecules, Drugs and Crops
Start: 2025-09-24T18:30:00.000+02:00
End: 2025-09-24T21:30:00.000+02:00
Location: Berlin, Berlin

idalab Seminar

Register to See Address

Berlin, Berlin

Approval Required

Your registration is subject to approval by the host.

Welcome! To join the event, please register below.

You will be asked to verify token ownership with your wallet.

About Event

Abstract

Join us for an evening on how AI is redefining what’s possible in synthetic biology, spanning next-generation medicines, sustainable manufacturing, and the global food industry.

Synthetic biology holds the promise of sustainable chemicals, advanced biomolecules, and resilient crops. Yet biology’s complexity makes the journey from lab to market long, costly, and unpredictable.

AI is changing that. From protein design and enzyme engineering to strain optimization and bioprocess scale-up, AI tools are unlocking capabilities once out of reach.

This panel brings together perspectives from a protein-design startup for pharma and life sciences, a biotech creating novel materials, and a deep-tech venture capital investor. We’ll explore how AI is enabling the next wave of medicines, materials and, and food – and what investors look for in AI-driven synbio biology ventures.

Panelists

Dr. Ingmar Schuster
Ingmar is the Co-founder and CEO of Provolut, a German biotech startup. Provolut focuses on designing and optimizing proteins using AI for biotech, pharma and chemistry clients.

Pierre Salvy, PhD
Pierre is the CTO at Cambrium. The company uses generative AI and biotechnology to design, develop, and scale new molecules to power the chemistry of tomorrow.

Dr. Carolina Villa
Carolina is Principal at Nucleus Capital, a deep-tech VC focused on Programmable Biology, Food Technology and Green Industrials.

Agenda

18:30 - Doors open
19:00 - Panel starts
20:00 - Drinks and networking

Location

Please register to see the exact location of this event.